Abstract
The impact of recombinant human tumour necrosis factor-alpha (1 microgram kg-1 to 1 mg kg-1; 6.6 x 10(6) U mg protein-1) on blood flow, oxygen consumption and growth of a moderately TNF-sensitive rat tumour (DS-carcinosarcoma) was studied. Tumour growth was stimulated at low TNF doses (1 and 10 micrograms kg-1) and significantly retarded at higher TNF dose levels (0.1 and 1 mg kg-1). Growth changes were concomitant with variations in oxygen consumption, lactate release and acidification of the metabolic micromilieu. Both single and repeated application of low TNF doses (1-10 micrograms kg-1 i.v.) increased tumour perfusion whereas single administration of high TNF dose levels (0.1-1 mg kg-1 i.v.) reduced tumour blood flow. After repeated application of high TNF doses tumours shrank to such small sizes that perfusion measurements could not be performed within the observation period of two weeks. It is concluded that TNF effects on solid tumours are at least partially mediated by changes in tumour perfusion. Thus, an altered tumour sensitivity towards other treatment modalities, e.g. irradiation, chemotherapy or hyperthermia, can be expected after TNF therapy. A beneficial TNF effect would critically depend on the dose level employed and on the sequence and timing of various combination regimes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kallinowski, F., Schaefer, C., Tyler, G. et al. In vivo targets of recombinant human tumour necrosis factor-α: blood flow, oxygen consumption and growth of isotransplanted rat tumours. Br J Cancer 60, 555–560 (1989). https://doi.org/10.1038/bjc.1989.312
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.312
This article is cited by
-
Drug Insight: vascular disrupting agents and angiogenesis—novel approaches for drug delivery
Nature Clinical Practice Oncology (2006)
-
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas
Investigational New Drugs (2006)
-
Disrupting tumour blood vessels
Nature Reviews Cancer (2005)
-
In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
British Journal of Cancer (1999)
-
Splanchnic metabolism associated with liver metastasis
Intensive Care Medicine (1995)